.
ResMed Inc (ASX:RMD) earned $73 million in the fourth quarter ended June 30.
The maker of devices for sleep-disordered breathing, ResMed says it had record revenue for the quarter of $414.6 million - 11 per cent more than the same quarter last year.
For the year ended June 30, 2013, net income was $307.1 million, an increase of 21 percent over the previous year.
The company says fourth quarter net income was reduced by a $17.7 million charge for settling litigation with the University of Sydney.
CEO Mick Farrell says the quarterly dividend has increased 47 per cent to 25 cents per share.
News: ResMed earns $73M in quarter
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$37.28 |
Change
0.200(0.54%) |
Mkt cap ! $22.38B | |||
| Open | High | Low | Value | Volume |
| $37.50 | $37.55 | $37.15 | $17.93M | 480.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3363 | $37.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $37.30 | 1001 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |
